Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data
Bio Expo
Champignondagen
  • News
  • Press Releases
  • Research
  • Business
  • Regulatory
  • Events and Conferences
The Pharma Data
  • Press Releases

Lilly Announces Executive Leadership Changes

  • The Pharma Data
  • May 9, 2025

Eli Lilly Announces Executive Leadership Changes to Propel Future Growth Eli Lilly and Company (NYSE: LLY) today announced a series of executive leadership transitions designed to strengthen its ability to…

Read MoreLilly Announces Executive Leadership Changes
  • News

Teva to Host Innovation and Strategy Day on May 29 in New York City

  • The Pharma Data
  • May 8, 2025

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) stands as a unique global biopharmaceutical leader, delivering a wide range of medicines to patients around the world. With a legacy spanning…

Read MoreTeva to Host Innovation and Strategy Day on May 29 in New York City
  • Press Releases

Otsuka and Keio Partner on Psychedelics Research for Social Implementation in Japan

  • The Pharma Data
  • May 8, 2025

Otsuka Pharmaceutical Signs Research Agreement with Keio University to Advance Psychedelic Treatment Infrastructure in Japan Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced that it has signed a non-clinical (basic research)…

Read MoreOtsuka and Keio Partner on Psychedelics Research for Social Implementation in Japan
  • Press ReleasesBusiness

Argenx Announces Q1 2025 Financial Results and Business Update

  • The Pharma Data
  • May 8, 2025

argenx SE (Euronext & Nasdaq: ARGX), a global immunology company focused on improving the lives of people with severe autoimmune diseases, today announced its financial results for the first quarter…

Read MoreArgenx Announces Q1 2025 Financial Results and Business Update
Zai Lab
  • Press ReleasesBusiness

Takeda Reports FY2024 Results & FY2025 Growth Outlook

  • The Pharma Data
  • May 8, 2025

Strong FY2024 Performance and Strategic Outlook for FY2025 The company reported core revenue growth of 7.4% at actual exchange rates (AER) and 2.8% at constant exchange rates (CER) for fiscal…

Read MoreTakeda Reports FY2024 Results & FY2025 Growth Outlook
  • ResearchNews

Final Phase 3 MYR301 Data: Longer Bulevirtide Use Sustains Undetectability Post-Treatment

  • The Pharma Data
  • May 8, 2025

90% of Adults with Chronic Hepatitis Delta Who Cleared Virus on Bulevirtide Stayed Clear Nearly 2 Years After Stopping Treatment Gilead Sciences, Inc. (Nasdaq: GILD) today announced final results from…

Read MoreFinal Phase 3 MYR301 Data: Longer Bulevirtide Use Sustains Undetectability Post-Treatment
  • Press Releases

New EASL 2025 Data: Gilead’s Livdelzi® (Seladelpar) Effective and Safe Regardless of Prior Treatments

  • The Pharma Data
  • May 8, 2025

Gilead Sciences, Inc. (Nasdaq: GILD) today announced new data from multiple analyses which reinforce that Livdelzi® (seladelpar), known as Lyvdelzi® in the European Union, is effective and generally well-tolerated for the treatment…

Read MoreNew EASL 2025 Data: Gilead’s Livdelzi® (Seladelpar) Effective and Safe Regardless of Prior Treatments
  • Research

Enhertu + THP Boosts pCR in High-Risk HER2+ Early Breast Cancer: DESTINY-Breast11

  • The Pharma Data
  • May 8, 2025

Enhertu Plus THP Shows Improved Safety and Efficacy Over Standard of Care in Early HER2-Positive Breast CancerAstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan), followed by a regimen of paclitaxel, trastuzumab,…

Read MoreEnhertu + THP Boosts pCR in High-Risk HER2+ Early Breast Cancer: DESTINY-Breast11
  • BusinessPress Releases

Novo Nordisk Reports 19% Sales Growth to DKK 78.1 Billion in Q1 2025

  • The Pharma Data
  • May 8, 2025

Novo Nordisk Reports Strong Operating Profit and Sales Growth, Updates 2025 Outlook Novo Nordisk announced a 22% increase in operating profit in Danish kroner, or 20% growth at constant exchange…

Read MoreNovo Nordisk Reports 19% Sales Growth to DKK 78.1 Billion in Q1 2025
  • Press Releases

Roche Launches Elecsys PRO-C3 Test to Enhance Accuracy in Liver Fibrosis Assessment

  • The Pharma Data
  • May 6, 2025

Roche (SIX: RO, ROG; OTCQX: RHHBY) has announced the launch of its Elecsys® PRO-C3 test, a new diagnostic tool developed in collaboration with Nordic Bioscience, to assess the severity of…

Read MoreRoche Launches Elecsys PRO-C3 Test to Enhance Accuracy in Liver Fibrosis Assessment
  • News

Health Inequities Are Cutting Lives Short by Decades

  • The Pharma Data
  • May 6, 2025

Global Health Inequities Slashing Lifespans by Decades, WHO Warns A new report by the World Health Organization (WHO) reveals that the root causes of poor health often lie outside the…

Read MoreHealth Inequities Are Cutting Lives Short by Decades
  • Regulatory

Teva and Alvotech Receive FDA Approval for SELARSDI™ as an Interchangeable Biosimilar to Stelara

  • The Pharma Data
  • May 6, 2025

Teva and Alvotech Expand U.S. Biosimilar Portfolio with Approval for SELARSDI™ Teva Pharmaceuticals, the U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Alvotech (NASDAQ: ALVO) have…

Read MoreTeva and Alvotech Receive FDA Approval for SELARSDI™ as an Interchangeable Biosimilar to Stelara
PrevNext
UK Biotech Day
Global Clinical
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • Curi Bio and Battelle Partner to Advance Neuromuscular Pharmacology Innovations
  • ImmunityBio Secures Macau Approval for ANKTIVA® to Treat BCG-Unresponsive NMIBC with CIS With or Without Papillary Tumors
  • KalVista to Showcase New EKTERLY® Data at 2026 Global Angioedema Conference
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.